Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …

The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …

Plasma free fatty acid (FFA) concentration is elevated in obesity, insulin resistance (IR), non-
alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and related comorbidities such …

During the COVID-19 pandemic, people have reduced the frequency of going out, and need
to engage in health behaviors at home. Home-based exercise has aroused people's …

One of the focuses of non-alcoholic fatty liver disease (NAFLD) treatment is exercise.
Randomized controlled trials investigating the effects of exercise without dietary changes on …

Sedentarism is the pandemic of modern times. It is associated with several medical
conditions including obesity, type 2 diabetes mellitus, cardiovascular diseases and also liver …

Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …

This systematic review examined the impact of exercise intervention programs on selected
cardiometabolic health indicators in adults with overweight or obesity. Three electronic …